Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study.
Journal of Clinical Oncology.
Times cited: 23
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy.
Times cited: 30